| Programs + Specialties |
|
| Training + Education |
University of Cape Town Faculty of Health Sciences, South Africa; Brigham and Women's Hospital; Massachusetts General Hospital; Yale-New Haven Hospital
|
| Board Certifications |
Maternal Fetal Medicine, Obstetrics and Gynecology |
| NPI # |
1760465819 |
| Gender |
Male |
| Accepted Insurances |
View Accepted Insurances at Tufts MC + Floating Hospital |
Tufts Medical Center
800 Washington St, #324
Boston, MA 02111
Phone #: 617-636-2382
Fax #: 617-636-8315
|
2019, Appointed President-Elect, Council of University Chairs of Obstetrics & Gynecology (CUCOG)
2019, Member, Board of Scientific Counselors, NICHD, Bethesda, MD
2019, Appointed Member National Advisory Council, NICHD
2017, Rochester General Hospital Association Teaching Fellowship, Department of OB/GYN, Rochester General Hospital, Rochester, NY
2011-present, Top Doctors in Boston
2011, The March of Dimes Award for Best Research in Prematurity at SMFM, San Francisco, CA
2011, Best Oral Presentation at SMFM, San Francisco, CA
2009, Best Doctors in Connecticut 2009-2010
2008, Best Oral Presentation at SMFM, Dallas, TX
2007, Fellow, American Gynecological and Obstetrical Society (AGOS)
2007-2011, America’s Top Obstetricians and Gynecologists, Consumer’s Research Council of America
2006-present, Fellow, Timothy Dwight College, Yale College, New Haven, CT
2006, The Charles A. Hunter Jr. Prize Thesis Award, 25th Annual Meeting of American Gynecological and Obstetrical Society, Williamsburg, VA
2006, The March of Dimes Award for the Best Research in Prematurity at SMFM, Miami, FL
2005-present, Best Doctors in America
2005, Best Poster Presentation at SMFM, Reno, NV
2004, The Zuspan Award for the Best Oral Presentation, Society for Obstetric Anesthesia and Perinatology (SOAP), Ft. Myers, FL
2003, Best Oral Presentation at SMFM, New Orleans, LA
2002, Best Oral Presentation at ACOG Distinct I Annual Meeting, Southampton, Bermuda
2001, Rochester General Hospital Association Teaching Fellowship, Department of OB/GYN, Rochester General Hospital, Rochester, NY
2000, Best Oral Presentation at the New England Perinatal Society, Manchester Village, VT
1999, Quest Diagnostics Award for Best Oral Presentation, The Endocrine Society, San Diego, CA
1999, Best Oral Presentation at New England Conference on Perinatal Research, Chatham, MA
1991, Best Poster Presentation at the 2nd European Congress on Prostaglandins in Reproduction, The Hague, the Netherlands
1988-1991, The Rhodes Scholarship (Southern Africa at Large), Oxford University, UK
FOR A COMPLETE LIST OF DR. NORWITZ’S PUBLICATIONS, SEE:
PubMed
Selected Presentations:
"Women's Health Without Borders" [panel discussion] Magee-Womens Research Summit, David L. Lawrence Convention Center, Pittsburgh, PA, October, 2018.
“How to interpret cord blood gases;” “Optimal timing of delivery: Should it be 39 weeks and out?”; “Obesity in pregnancy”; and “Management of preeclampsia,”36th Annual Fall Conference on Obstetrics, Symposia Medicus, JW Marriott Guanacaste Resort & Spa, Guanacaste, Costa Rica, October, 2018.
"Is there a role of genetic testing to predict pregnancy complications?" Illumina, Reproductive and Genetic Health Clinical Expert Panel, Montreal, Canada, September, 2018.
"New guidelines on thromboprophylaxis in pregnancy;" and "Morbid obesity in pregnancy: a growing problem;" 17th Annual Congress of the Society of Obstetrics and Gynecology of Romania (SOGR), Iaci, Romania, September, 2018.
“10 things I wish someone had told me before I became Chair;” and “Professional Development: Achieving clinical and academic excellence in a time of diminished resources;” 3rd Biannual ACOG Course on Essentials for the New Ob-Gyn Department Chair, ACOG, Washington, DC, August, 2018.
“Preterm birth: A global healthcare pandemic in search of an integrated solution,” 3rd Annual Rhodes Healthcare Forum: Forward Together: Approaching Global Inequities in Health, Rhodes House, Oxford, UK November, 2017.
“Prenatal diagnosis of placental diseases: role of ultrasound;” “SLE: preconception counseling and perinatal management;” and “Management of thyroid disease in pregnancy;” The Third China-U.S. Forum on Women and Children’s Healthcare, Nanning, Guangxi Province, PR China, July, 2017.
“Molecular regulation of adverse pregnancy outcome: Inflammation and the decidual clock,” Pre-ASRI Annual Meeting Clinical Symposium, 36th Annual Scientific Meeting of the American Society for Reproductive Immunology, Baltimore, MD, November, 2016.
“Obesity in pregnancy;”“Management dilemmas of the post-term pregnancy;” “Preterm labor: Mechanisms and management;” and “Endocrine emergencies in the pregnant patient,” 34th Annual Fall Conference on Obstetrics, Symposia Medicus, Westin Grand Cayman Seven Mile Beach Resort & Spa, Grand Cayman, Cayman Islands, October, 2016.
Errol Norwitz, MD, is internationally recognized for his work in maternal-fetal medicine, particularly in the causes and prevention of preeclampsia and pre-term labor. His research includes the use of progesterone to delay preterm labor in high-risk women, the genetics of adverse pregnancy outcomes, and the molecular regulation of labor and delivery, both term and preterm. He is the Chair of Obstetrics and Gynecology at Tufts Medical Center, and a professor at Tufts University School of Medicine. He is board certified in Maternal Fetal Medicine and Obstetrics and Gynecology.
President, Pratt Ob/Gyn, Boston, MA
Medical Board, Tufts Medical Center, Boston, MA
Research Council, Tufts Medical Center, Boston, MA
Editor-in-Chief, Reviews in Obstetrics & Gynecology
2007-2010, Member, Obstetric Practice Committee, Yale-New Haven Hospital
2007-2010, Member, Gynecology Practice Committee, Yale-New Haven Hospital
2003-2010, Member, Quality Assessment Comm., Dept. of Ob/Gyn. & Repr. Biology, Yale-New Haven Hospital
2003, Chair, Mortality & Morbidity Conf., Dept. of Ob/Gyn. & Repr. Sciences, Yale-New Haven Hospital
NIH/NICHD (R01HD049446)
2011-2016
Innate Immune Responses of Trophoblasts in Pregnancy.
The major goals of this project are to determine the regulation of TLR-2 and TLR-8 mediated inflammation and apoptosis in the normal first trimester trophoblast in response to bacterial and viral components.
Role: Co-Investigator
NIH/NICHD (P01HD054713)
2009-2014
Program: Function of Toll-Like Receptors Throughout Gestation.
Project: Role of Toll-Like Receptors and Glucocorticoid in Placental-Fetal Inflammation.
The major goals of this project are to understand the function of Toll-like receptors at the maternal-fetal interface throughout gestation, and their role in infection-associated pregnancy complications. These studies will focus on the inflammatory
function of TLRs 3 and 4 in the first trimester placenta (Project I) and the inflammatory function of TLRs 2, 3 and 4 in the decidua (Project II) and term placenta (Project III).
Role: Co-Investigator
Burroughs Wellcome Fund
2009-2010
The Role of Placental Nod-Like Receptors in Infection-Associated Preterm Labor.
The major goals of this project are to determine the function of NLRs in the placenta and their role in infection-associated preterm labor.
Role: Co-Investigator
March of Dimes
2006-2010
Progesterone Receptor Dysregulation and Preterm Birth.
To understand in detail the molecular mechanisms by which progesterone supplementation can prevent preterm birth in some high-risk parturients and, in particular, to characterize the role of the progesterone receptor in spontaneous preterm labor.
Role: Principal Investigator.
Vision Grant Award (Panda)
2008-2009
Preeclampsia Foundation
Role of TLR in Preeclampsia.
The major goal of this project was to delineate the role of TLR in the pathogenesis of preeclampsia.
Role: Co-Investigator
NIH/NICHD (R01HD047321
2004-2010
A Proteomics Computational Approach to Preterm Delivery.
Uses proteomics and computational tools to classify pathogenetic entities within the preterm labor syndrome and identifies biomarkers with diagnostic and prognostic value.
Role: Co-Investigator
